Fig1 (Tizanidine Fig1)
Tizanidine Hydrochloride Capsule
Product Images NDC 59651-314
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 59651-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig2 (Tizanidine Fig2)
Fig3 (Tizanidine Fig3)
The text describes an improvement in the Ashworth Score using Tizanidine with a mean dose of 28.8 mg compared to a placebo. The data is presented for the end of titration, end of maintenance, and endpoint (last observation carried forward).*
Package Label-principal Display Panel (2 mg (150 Capsules Bottle))
This is a description of Tizanidine Hydrochloride Capsules. Each capsule contains 2.287 mg of tizanidine hydrochloride USP, which is equivalent to 2 mg tizanidine base. The usual dosage information is provided in the package insert. It should be stored at room temperature and out of reach of children. Zanaflex® is a registered trademark of Acorda Therapeutics Inc. These capsules are distributed by Aurobindo Pharma USA, Inc. and are made in India.*
Package Label-principal Display Panel (4 mg (150 Capsules Bottle))
This is a description of Tizanidine Hydrochloride Capsules manufactured by Ajanta Pharma. It contains 150 capsules that consist of 4mg Tizanidine base, indicated for muscle relaxation. Dosage details must be referred from the package insert. The capsules are to be stored at room temperature and in containers with a child-resistant closure. The drug must be kept out of children's reach. Distributed by Aurabindo Pharma in the USA, this drug is produced in India. There are also details about the code, manufacturing date, and the name of the registered trademark. The rest of the text is related to printing and packaging.*
Package Label-principal Display Panel (6 mg (150 Capsules Bottle))
This is a description of Tizanidine Hydrochloride Capsules, which come in a bottle of 150 capsules. Each capsule contains 6.862 mg of tizanidine hydrochloride USP, which is equivalent to 6 mg of tizanidine base. The usual dosage should be referred to the package insert for prescribing information. It is recommended to store at a temperature of 20° to 25°C (68° to 77°F) and keep it out of reach of children. The medicine is distributed by Aurobindo Pharma USA, Inc. in East Windsor, NJ, and manufactured in India. Zanaflex® is a registered trademark of Acorda Therapeutics Inc. There is some other information given but it is not useful for the description.*
Str (Tizanidine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
